Preanalytical monitoring enables laboratories to demonstrate and document regulatory compliance as it expands beyond breast tumor markers such as HER2, ER, and PR11 and into other disease biomarkers20 and enable the biorepository to better curate their collection of biospecimens for research purposes. The gene discussed is ERBB2; the disease is breast neoplasm.